Skip to content

Relationship Between Cardiovascular Disease in Asthma and Eosinophil Subtypes and Biomarkers of Bronchial Remodeling.

Relationship Between Cardiovascular Disease in Asthma and Eosinophil Subtypes and Biomarkers of Bronchial Remodeling.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05589779
Enrollment
40
Registered
2022-10-21
Start date
2023-04-01
Completion date
2024-08-01
Last updated
2022-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Cardiovascular Diseases

Keywords

Asthma, Cardiovascular Diseases, Chronic inflammation, Bronchial remodeling, Eosinophilia

Brief summary

To know the clinical and inflammatory characteristics of patients with asthma and associated cardiovascular disease.

Detailed description

Recent studies have shown that asthma could be a risk factor for cardiovascular disease, especially in the female and late-onset subgroups. The two entities share several risk factors, such as chronic inflammation and bronchial remodeling. Eosinophilia, characteristic of asthma, has also been described as a predictor of cardiovascular mortality. The aim of this study is to determine the clinical and inflammatory characteristics of patients with asthma and associated cardiovascular disease, as well as their relationship with eosinophil subtypes, biomarkers of chronic inflammation and bronchial remodeling.

Interventions

OTHERAsthma and cardiovascular disease

To know the clinical and inflammatory characteristics of patients with asthma and associated cardiovascular disease, as well as their relationship with eosinophil subtypes, biomarkers of chronic inflammation and bronchial remodeling.

Sponsors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Previous diagnosis of asthma * Signed informed consent

Exclusion criteria

* Age under 18 years old * Age over 99 years old * Pneumological diseases other than asthma * Active oncological diseases or with end of treatment \<5 years * Autoimmune or systemic inflammatory diseases

Design outcomes

Primary

MeasureTime frameDescription
Clinical characteristics of patients with asthma1 yearSpirometry with bronchodilator testing
Associated cardiovascular disease type1 yearCardiac infarction, stroke or peripheral artery disease

Secondary

MeasureTime frameDescription
Eosinophil subtypes1 yearEosinophil subtypes of patients with asthma and cardiovascular disease
Biomarkers of chronic inflammation1 yearTransforming growth factor-β, interleukin-5, interleukin-13, interleukin-25 and interleukin-3
Bronchial remodeling1 yearBronchial remodeling of patients with asthma and cardiovascular disease measured by analysis of images obtained by thoracic CT scanning

Contacts

Primary ContactEsther Palones, MD
epalones@santpau.cat+34 93 556 56 01

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026